Yes, he should receive the flu vaccine now
A 42-year-old man who recovered from influenza two months ago should receive the seasonal flu vaccine without delay. Having had influenza earlier in the season does not provide complete protection against other circulating influenza strains and does not contraindicate vaccination 1.
Key Reasoning
No Contraindication from Prior Infection
The ACIP guidelines for the 2025-26 influenza season specify clear contraindications to flu vaccination: severe allergic reactions to vaccine components or previous doses 1. Prior influenza infection is not listed as a contraindication or precaution 1. The guidelines recommend routine annual influenza vaccination for all persons aged ≥6 months without contraindications 1.
Why Vaccination Is Still Beneficial
Multiple strains circulate: Seasonal influenza vaccines are trivalent, protecting against three different influenza viruses 1. Having had one influenza infection does not guarantee protection against other circulating strains during the same season.
Vaccine effectiveness persists: Research shows that inactivated influenza vaccine maintains protective antibody levels (HAI titres) for 5-7 months post-vaccination in adults aged 18-65 years 2. Even with some waning, vaccine effectiveness remains significant throughout the season, particularly for influenza A/H1 strains 2.
Timing considerations: While some waning occurs over time, delaying vaccination provides no substantial population-level benefit 3. The evidence does not support waiting to vaccinate based on prior infection 3.
Practical Administration
For this 42-year-old male:
- One dose only is required (all persons aged ≥9 years need only one dose) 1
- Any age-appropriate vaccine can be used (no preferential recommendation for adults under 65 years) 1
- 0.5 mL intramuscular injection is the standard dose 1
Common Pitfall to Avoid
Do not assume that recent influenza infection provides adequate immunity for the remainder of the season. Natural infection with one strain does not protect against other circulating strains, and the vaccine offers broader protection against multiple influenza types and subtypes.